Skip to main content

Peer Review reports

From: Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study

Original Submission
20 Feb 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
3 Apr 2022 Reviewed Reviewer Report
22 Apr 2022 Reviewed Reviewer Report
12 May 2022 Author responded Author comments - Lin Yang
Resubmission - Version 4
12 May 2022 Submitted Manuscript version 4
22 May 2022 Author responded Author comments - Lin Yang
Resubmission - Version 5
22 May 2022 Submitted Manuscript version 5
15 Jun 2022 Reviewed Reviewer Report
24 Jun 2022 Author responded Author comments - Lin Yang
Resubmission - Version 6
24 Jun 2022 Submitted Manuscript version 6
Publishing
4 Jul 2022 Editorially accepted
21 Jul 2022 Article published 10.1186/s12885-022-09889-3

You can find further information about peer review here.

Back to article page